The present invention relates to a solid oral dosage form comprising about 0.5 mg estradiol and about 0.25 mg drospirenone and at least one pharmaceutically acceptable excipient and to the package unit of the dosage form. The solid oral dosage form can be used for preventing, treating or alleviating vasomotor symptoms, lowering the frequency of breakthrough bleedings or increasing the incidence rate of amenorrhea in a woman.本發明係關於一種固體口服劑型,其包含約0.5 mg雌二醇及約0.25 mg屈螺酮(drospirenone)及至少一種醫藥學上可接受之賦形劑,及關於該劑型之包裝單位。該固體口服劑型可用於預防、治療或減輕女性血管舒縮症狀,降低女性突破性(breakthrough)出血頻率,或增加女性停經發生率。